Koshinski Asset Management, Inc. Kintara Therapeutics, Inc. Transaction History

Koshinski Asset Management, Inc.

  • $1.13 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022
SELL
$0.14 - $0.5 $560 - $2,000
-4,000 Closed
0 $0
Q4 2021

Jan 14, 2022
BUY
$0.51 - $1.04 $1,020 - $2,080
2,000 Added 100.0%
4,000 $2.04 Million
Q3 2021

Oct 12, 2021
BUY
$0.82 - $2.3 $1,640 - $4,600
2,000 New
2,000 $1,000

About Kintara Therapeutics, Inc.

KTRA Quotes by TradingView
  • Ticker KTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,807,296
  • Market Cap $17.8M
  • Description
  • Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...
More about KTRA
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email